Clinical trial
Registry to Prospectively Evaluate Use of Ventavis® in Patients With Pulmonary Arterial Hypertension
NCT00902603 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Registry to Prospectively Evaluate Use of Ventavis® in Patients With Pulmonary Arterial Hypertension
- Lead sponsor
- Actelion
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 31, 2009
- Completion date
- February 28, 2014
- Enrollment
- 148 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.